NASDAQ:BMTI - BioMimetic Therapeutics Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About BioMimetic Therapeutics (NASDAQ:BMTI)

BioMimetic Therapeutics logoBioMimetic Therapeutics, Inc. is a biotechnology company engaged in developing and commercializing products to the healing of musculoskeletal injuries and diseases, including therapies for orthopedic, sports medicine and spine applications. The Company's Augment platform of product and product candidates include an engineered version of recombinant human platelet-derived growth factor BB (rhPDGF-BB), one of the wound healing and tissue repair stimulators in the body. Its platform regenerative technology for promoting tissue healing and regeneration combines rhPDGF-BB with tissue specific matrices, when appropriate. The matrices are engineered or natural scaffold materials, such as Beta Tri-Calcium Phosphate. The Company's product candidates include Augment Bone Graft (Augment), Augmen Injectable Bone Graft (Augment Injectable) and Augment Rotator Cuff Graft (Augment Rotator Cuff Graft). In March 2013, Wright Medical Group Inc completed acquisition of BioMimetic Therapeutics, Inc.

Receive BMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for BMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

BioMimetic Therapeutics (NASDAQ:BMTI) Frequently Asked Questions

What is BioMimetic Therapeutics' stock symbol?

BioMimetic Therapeutics trades on the NASDAQ under the ticker symbol "BMTI."

Who are some of BioMimetic Therapeutics' key competitors?

Has BioMimetic Therapeutics been receiving favorable news coverage?

Media stories about BMTI stock have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. BioMimetic Therapeutics earned a news impact score of 0.13 on Accern's scale. They also assigned news headlines about the biotechnology company an impact score of 46.88 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of BioMimetic Therapeutics?

Shares of BMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact BioMimetic Therapeutics?

BioMimetic Therapeutics' mailing address is 389 Nichol Mill Lane, FRANKLIN, TN 37067, United States. The biotechnology company can be reached via phone at +1-615-8441280.

MarketBeat Community Rating for BioMimetic Therapeutics (BMTI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  103
MarketBeat's community ratings are surveys of what our community members think about BioMimetic Therapeutics and other stocks. Vote "Outperform" if you believe BMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BioMimetic Therapeutics (NASDAQ:BMTI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/21/2016 forward)


BioMimetic Therapeutics (NASDAQ:BMTI) Earnings History and Estimates Chart

Earnings by Quarter for BioMimetic Therapeutics (NASDAQ:BMTI)

BioMimetic Therapeutics (NASDAQ BMTI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/5/2012Q312($0.23)($0.16)ViewN/AView Earnings Details
8/2/2012Q2 2012($0.21)($0.23)ViewN/AView Earnings Details
5/9/2012Q1 2012($0.21)($0.22)ViewN/AView Earnings Details
3/13/2012Q4 2011($0.26)($0.25)ViewN/AView Earnings Details
11/8/2011Q3 2011($0.32)($0.25)ViewN/AView Earnings Details
8/4/2011Q2 2011($0.33)($0.29)ViewN/AView Earnings Details
5/9/2011Q1 2011($0.35)($0.29)ViewN/AView Earnings Details
3/10/2011Q4 2010($0.34)($0.36)ViewN/AView Earnings Details
11/3/2010Q3 2010($0.31)($0.29)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.38)($0.35)ViewN/AView Earnings Details
5/10/2010Q1 2010($0.36)($0.39)ViewN/AView Earnings Details
3/11/2010Q4 2009($0.41)($0.16)ViewN/AView Earnings Details
11/5/2009Q3 2009($0.42)($0.36)ViewN/AView Earnings Details
8/10/2009Q2 2009($0.47)($0.32)ViewN/AView Earnings Details
5/7/2009Q1 2009($0.48)($0.43)ViewN/AView Earnings Details
3/12/2009Q4 2008($0.53)($0.43)ViewN/AView Earnings Details
11/10/2008Q3 2008($0.51)($0.42)ViewN/AView Earnings Details
8/11/2008Q2 2008($0.40)($0.50)ViewN/AView Earnings Details
5/8/2008Q1 2008$1.36$1.62ViewN/AView Earnings Details
3/12/2008Q4 2007($0.31)($0.37)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


BioMimetic Therapeutics (NASDAQ:BMTI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

BioMimetic Therapeutics (NASDAQ BMTI) Insider Trading and Institutional Ownership History

Insider Trading History for BioMimetic Therapeutics (NASDAQ:BMTI)

BioMimetic Therapeutics (NASDAQ BMTI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


BioMimetic Therapeutics (NASDAQ BMTI) News Headlines

No headlines for this company have been tracked by

SEC Filings

BioMimetic Therapeutics (NASDAQ:BMTI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


BioMimetic Therapeutics (NASDAQ:BMTI) Income Statement, Balance Sheet and Cash Flow Statement


BioMimetic Therapeutics (NASDAQ BMTI) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.